PPA provides normal and disease state products, biological specimens, and related Products and Services to disease researchers worldwide in order to advance research and improve the lives of individuals living with chronic and infectious diseases. Read more here.
Randox Biosciences have been developing and manufacturing antibodies, proteins and conjugates for over 30 years for use in Randox Laboratories diagnostic kits, including our patented Biochip Array Technology kits. We offer an extensive portfolio of over 900 products for a multitude of R&D applications including more than 500 monoclonal and polyclonal antibodies and over 140 human recombinant proteins as well as antibody fragments. In addition we also offer a customisation service for all products… Read more here.
A critical factor facing the Cell Therapy industry is choosing technologies and partners that can deliver scale. There’s no other field of medicine that requires the level of mass customization of production and careful orchestration of production pathways that cell therapies demand. From sample collection through logistics, manufacturing and final transplantation, TrakCel’s proven technology integrates and orchestrates every aspect of your Autologous and Allogeneic supply chains in a scalable, compliant and validated technology platform.
World Courier is a global specialty logistics company that designs world-class logistics and supply chain programs in complete alignment with our customers’ business goals. Pharmaceutical companies rely on us because they value the peace of mind that comes with our unsurpassed knowledge, global reach and flawless supply chain execution. Read more here.
Immatics is a clinical-stage biopharmaceutical company active in the discovery and development of T-cell redirecting immunotherapies for the treatment of cancer. Our transformative product candidates are – best in class – Adoptive Cell Therapies and Bispecific TCR molecules. These products are directed against tumor targets that have been identified and validated by Immatics’ proprietary and world-leading XPRESIDENT® technology. Our mission is to bring the power of T-cell redirecting immunotherapies to cancer patients.
Noile-Immune Biotech is a Tokyo-based clinical stage biotechnology company focused on the development of next generation CAR-T cells for solid tumors. Our proprietary Prime (Proliferation-inducing and migration-enhancing) CAR-T technology which express particular combination of IL-7 and CCL19, is designed to enhance anti-tumor potential by enabling infiltration, accumulation, and survival of CAR-T cells in coordination with activation of tumor-reactive host T cells and their memory formation. Read more here.